Sharp Therapeutics Corp. (TSXV:SHRX)

Canada flag Canada · Delayed Price · Currency is CAD
1.700
+0.050 (3.03%)
At close: Apr 24, 2025
-22.73%
Market Cap 52.21M
Revenue (ttm) n/a
Net Income (ttm) -6.73M
Shares Out 28.22M
EPS (ttm) -48.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,203
Average Volume 2,976
Open 1.700
Previous Close 1.650
Day's Range 1.700 - 1.700
52-Week Range 1.800 - 2.280
Beta n/a
RSI 46.91
Earnings Date n/a

About Sharp Therapeutics

Sharp Therapeutics Corp., a biology technology company, develops medicines specific for genetic diseases. It engages in the development of the CoreX biology, AlloChem chemistry, and Disco/Mine computational technologies to discover drugs that activate the protein altered by gene mutation. Sharp Therapeutics Corp. is based in Pittsburgh, Pennsylvania. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Scott Sneddon
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol SHRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.